About AVT
Browse Articles
Authors
Customer Services

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 21 Issue 8 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 2071 results:

Free
Original article

Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimen

Stéphane Chevaliez, Jordan Feld, Kevin Cheng, Heiner Wedemeyer, Christoph Sarrazin, Benjamin Maasoumy, Christine Herman, John Hackett, Daniel Cohen, George Dawson, Jean-Michel Pawlotsky, Gavin Cloherty

10.3851/IMP3042


Case report

Elvitegravir/cobicistat-associated toxic optical neuropathy in an HIV-infected patient: a call for caution?

Agostino Riva, Alessandro Invernizzi, Chiara Resnati, Valeria Micheli, Dario Cattaneo, Cristina Gervasoni

10.3851/IMP3058


Original article

Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials

Ana Arias, Antonio Aguilera, Vicente Soriano, Laura Benítez-Gutiérrez, Gemma Lledó, Daniel Navarro, Ana Treviño, Esteban Otero, José M Peña, Valentín Cuervas-Mons, Carmen de Mendoza

10.3851/IMP3061


Original article

ITPA deficiency and ribavirin level are still predictive of anaemia in HCV–HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study)

Farid Kheloufi, Isabelle Poizot-Martin, Rodolphe Garraffo, Aude Tavenard, Sylvie Quaranta, Alain Renault, Thibault Lavrut, Marc Bourlière, Philippe Halfon, Lionel Piroth, Eric Bellissant, Bruno Lacarelle, Jean-Michel Molina, Caroline Solas, the ANRS HC27 BOCEPREVIH Study Group

10.3851/IMP3074


Original article

Liver fibrosis indices for identifying patients at low risk of developing hepatocellular carcinoma after eradication of HCV

Hidenori Toyoda, Toshifumi Tada, Yoshihiko Tachi, Takanori Hirai, Satoshi Yasuda, Takashi Honda, Kazuhiko Hayashi, Masatoshi Ishigami, Hidemi Goto, Takashi Kumada

10.3851/IMP3081


Short communication

Dolutegravir monotherapy as treatment de-escalation in HIV-infected adults with virological control: DoluMono cohort results

Celia Oldenbuettel, Eva Wolf, Ayla Ritter, Sebastian Noe, Silke Heldwein, Rita Pascucci, Carmen Wiese, Ariane Von Krosigk, Eva Jaegel-Guedes, Hans Jaeger, Annamaria Balogh, Christine Koegl, Christoph D Spinner

10.3851/IMP3082


Original article

Safety and efficacy of sofosbuvir plus ledipasvir with and without ribavirin for chronic HCV genotype-1 infection: a systematic review and meta-analysis

Hussien Ahmed, Ahmed Elgebaly, Abdelrahman Ibrahim Abushouk, Ali Mohamed Hammad, Attia Attia, Ahmed Negida

10.3851/IMP3083


Original article

Interchangeability between first-line generic antiretroviral products prequalified by WHO using adjusted indirect comparisons

Luther Gwaza, John Gordon, Jan Welink, Henrike Potthast, Hubert Leufkens, Matthias Stahl, Alfredo García-Arieta

10.3851/IMP3089


Correction

Correction: Safety and efficacy of sofosbuvir plus ledipasvir with and without ribavirin for chronic HCV genotype-1 infection: a systematic review and meta-analysis

Hussien Ahmed, Ahmed Elgebaly, Abdelrahman Ibrahim Abushouk, Ali Mohamed Hammad, Attia Attia, Ahmed Negida

10.3851/IMP3092


Original article

Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s

Theodoros Kelesidis, Thuy Tien T Tran, Todd T Brown, Carlee Moser, Heather J Ribaudo, Michael P Dube, Otto O Yang, Grace A McComsey, James H Stein, Judith S Currier

10.3851/IMP3093


Page:
Copyright © Nucleus Global 2017. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.